NCT00807586View on ClinicalTrials.gov

Corticosteroid Pulse After Ablation

PHASE4CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2013

Conditions

Atrial Fibrillation

Interventions

DRUG

Solumedrol

100mg, given once within 2 hours of the end of the ablation procedure

DRUG

Placebo

Normal saline (1.6 cc)

Trial Locations (1)

55407

Abbott Northwestern Hospital, Minneapolis

Sponsors

Collaborators (1)

Abbott Medical Devices

All Listed Sponsors

collaborator

Abbott Medical Devices

INDUSTRY

lead

Minneapolis Heart Institute Foundation

OTHER